TORONTO and CAMBRIDGE, MA, March 14, 2018 /PRNewswire/ – ProMIS Neurosciences, Inc. a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced its operational and financial results for the year ended December…
